Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MA04 - Novel Approaches with IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Immunooncology
-
+
MA04.05 - Outcomes in NSCLC Patients Treated with First-Line Pembrolizumab and a PD-L1 TPS of 50-74% vs 75-100% or 50-89% vs 90-100%
14:00 - 14:05 | Presenter: Mark M. Awad | Author(s): Elizabeth Jimenez Alguilar, Justin F Gainor, Sasha Kravets, Sara Khosrowjerdi, Christine A Lydon, Anika Adeni, Safiya Subegdjo, Hira Rizvi, Matthew D. Hellmann
- Abstract
Loading... -
+
MA04.11 - Neoantigen Targeting and T Cell Reshaping in Resectable NSCLC Patients Treated with Neoadjuvant PD-1 Blockade
14:40 - 14:45 | Presenter: Kellie Nicole Smith | Author(s): Margueritta El Asmar, Jiajia Zhang, Justina X Caushi, Zhicheng Ji, Valsamo Anagnostou, Tricia R Cottrell, Hok Yee Chan, Prerna Suri, Haidan Guo, Kristen A. Marrone, Jarushka Naidoo, Taha Merghoub, Jamie E Chaft, Matthew D. Hellmann, Janis M Taube, Julie R. Brahmer, Patrick M Forde, Victor Velculescu, Drew M Pardoll, Hongkai Ji
- Abstract
Loading...
-
+
OA05 - Clinical Trials in IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 106
- Type: Oral Abstract Session
- Track: Advanced NSCLC
-
+
OA05.01 - Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated with Anti-PD-(L)1 Therapy
13:30 - 13:40 | Presenter: Matthew D. Hellmann | Author(s): Pasi A Jänne, Mateusz Opyrchal, Navid Hafez, Luis E Raez, Dmitry Gabrilovich, Fang Wang, Peter Ordentlich, Susan Brouwer, Serap Sankoh, Emmett Schmidt, Michael L Meyers, Suresh S. Ramalingam
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-02 - Long-Term Outcomes with First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC: 3-Year Follow-Up from CheckMate 012
16:45 - 18:00 | Presenter: Scott J Antonia | Author(s): Scott N. Gettinger, Hossein Borghaei, Jonathan W. Goldman, Julie R. Brahmer, Neal E. Ready, David E Gerber, Laura Q Chow, Rosalyn Juergens, Scott A. Laurie, Frances A Shepherd, Xuemei Li, Ang Li, William J. Geese, Matthew D. Hellmann
- Abstract
Loading... -
+
P1.01-68 - Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 Status with Outcomes for Immune Checkpoint Inhibitors in Advanced NSCLC Patients
16:45 - 18:00 | Presenter: Laura Mezquita | Author(s): Wungki Park, Kathryn C Arbour, Edouard Auclin, Lizza Hendriks, David Planchard, Diana Saravia, Santiago Ponce Aix, Ernest Nadal, Clarisse Audigier-Valette, Simona Carnio, Julien Adam, José Carlos Ruffinelli, Gerard Zalcman, Gianmauro Numico, Ivana Sullivan, Luis Paz-Ares, Anne-Marie C. Dingemans, Silvia Novello, Matthew D. Hellmann, Gilberto de Lima Lopes, Benjamin Besse
- Abstract
Loading...
-
+
MA16 - Novel Mechanisms for Molecular Profiling
- 13:30 - 15:00
- 9/25/2018
- Location: Room 203 BD
- Type: Mini Oral Abstract Session
- Track: Advanced NSCLC
-
+
MA16.04 - Clinical and Molecular Characteristics of EGFR Mutant Lung Cancers with Concurrent TP53 and RB1 Mutations.
13:55 - 14:00 | Presenter: Michael Offin | Author(s): Megan Tenet, Ronglai Shen, Natasha Rekhtman, Hira Rizvi, Matthew D. Hellmann, Maria E Arcila, Marc Ladanyi, Charles M. Rudin, Mark G Kris, Helena Yu
- Abstract
Loading...
-
+
MA19 - Genomic Markers of IO Response
- 15:15 - 16:45
- 9/25/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Immunooncology
-
+
MA19.01 - Efficacy and Genomic Correlates of Response to Anti-PD1/PD-L1 Blockade in Non-Small Cell Lung Cancers Harboring Targetable Oncogenes
15:15 - 15:20 | Presenter: Natalie Vokes | Author(s): Elizabeth Jimenez Alguilar, Anika Adeni, Renato Umeton, Lynette M Sholl, Hira Rizvi, Matthew D. Hellmann, Mark M. Awad, Eliezer M. Van Allen
- Abstract
Loading... -
+
MA19.09 - Concurrent Mutations in STK11 and KEAP1 is Associated with Resistance to PD-(L)1 Blockade in Patients with NSCLC Despite High TMB
16:10 - 16:15 | Presenter: Kathryn C Arbour | Author(s): Ronglai Shen, Andrew Plodkowski, Hira Rizvi, Ai Ni, Niamh Long, Darragh Halpenny, Francisco Sanchez-Vega, Charles M. Rudin, Gregory J Riely, Matthew D. Hellmann
- Abstract
Loading...
-
+
P2.06 - Mesothelioma (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.06-40 - VISTA is Highly Expressed in Malignant Pleural Mesothelioma (MPM) and Independent of PD-L1 Expression
16:45 - 18:00 | Presenter: Marjorie G. Zauderer | Author(s): Stephanie Muller, Wei-Chu Victoria Lai, Ai Ni, Achim Jungbluth, Michelle Ginsberg, Robert Daly, Matthew D. Hellmann, Marc Ladanyi, Jennifer Sauter
- Abstract
Loading...
-
+
P2.09 - Pathology (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.09-05 - Evaluation of PD-L1-Stained Tumor Cells via the 22C3 and SP-142 Antibodies in Cohort of Patients Treated on KEYNOTE-001
16:45 - 18:00 | Presenter: Aaron Lisberg | Author(s): Siwen Hu-Lieskovan, Tristan Grogan, James Carroll, Peter Shintaku, Mary Han, Dennis Slamon, Steven M Dubinett, Jonathan W. Goldman, David Elashoff, Matthew D. Hellmann, Antoni Ribas, Edward B Garon
- Abstract
Loading...